ORBIMED ADVISORS LLC – Crinetics Pharmaceuticals, Inc. Transaction History
ORBIMED ADVISORS LLC portfolio value:
$62.78M
portfolio value
ORBIMED ADVISORS LLC quarter portfolio value change:
+5.31%
quarter
Crinetics Pharmaceuticals, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | 0.00% | 0 shares | 3.16M | $19.64 | 3.19M | |
| Q2 2022 | share | 0.00% | 0 shares | -10.54M | $18.65 | 3.19M | |
| Q1 2022 | share | 0.00% | 0 shares | -20.65M | $21.95 | 3.19M | |
| Q4 2021 | share | Increase | +6.67% | 200K shares | 27.73M | $28.03 | 3.19M |
| Q3 2021 | share | 0.00% | 0 shares | 6.59M | $21.05 | 2.99M | |
| Q2 2021 | share | Increase | +8.84% | 243.30K shares | 14.41M | $18.85 | 2.99M |
| Q1 2021 | share | 0.00% | 0 shares | 3.22M | $15.28 | 2.75M | |
| Q4 2020 | share | 0.00% | 0 shares | -4.29M | $14.11 | 2.75M | |
| Q3 2020 | share | 0.00% | 0 shares | -5.09M | $15.67 | 2.75M | |
| Q2 2020 | share | Increase | +35.03% | 714.28K shares | 18.26M | $17.52 | 2.75M |
| Q1 2020 | share | 0.00% | 0 shares | -21.18M | $14.7 | 2.03M | |
| Q4 2019 | share | 0.00% | 0 shares | 20.49M | $25.09 | 2.03M | |
| Q3 2019 | share | 0.00% | 0 shares | -20.31M | $15.04 | 2.03M | |
| Q2 2019 | share | Increase | +6.53% | 125K shares | 7.41M | $25 | 2.03M |
| Q1 2019 | share | 0.00% | 0 shares | -13.84M | $22.76 | 1.91M | |
| Q4 2018 | share | 0.00% | 0 shares | 2.56M | $29.99 | 1.91M | |
| Q3 2018 | share | Increase | 0.00% | 1.91M shares | 54.84M | $28.65 | 1.91M |